Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 3/20 | 0.41 |
| ▸ | FPR3 | P25089 | 2/20 | 0.41 |
| ▸ | TSPO | P30536 | 2/20 | 0.41 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7222241 | 1.00 | CRHR1 (0.41) | CRHR1FPR3TSPOTMEM97 | |
| SCHEMBL7222238 | 1.00 | CRHR1 (0.41) | CRHR1FPR3TSPOTMEM97 | |
| SCHEMBL7220428 | 0.86 | CRHR1 (0.40) | CRHR1FPR3TSPOTMEM97 | |
| SCHEMBL7222459 | 0.86 | CRHR1 (0.40) | CRHR1FPR3TSPOTMEM97 | |
| SCHEMBL7220430 | 0.86 | CRHR1 (0.40) | CRHR1FPR3TSPOTMEM97 | |
| SCHEMBL7222451 | 0.85 | GABRG2 (0.34) | CRHR1FPR3TSPOTMEM97 | |
| SCHEMBL7222448 | 0.85 | GABRG2 (0.34) | CRHR1FPR3TSPOTMEM97 | |
| SCHEMBL7222445 | 0.85 | GABRG2 (0.34) | CRHR1FPR3TSPOTMEM97 | |
| SCHEMBL7220513 | 0.81 | CRHR1 (0.43) | CRHR1 | |
| SCHEMBL7220520 | 0.81 | CRHR1 (0.43) | CRHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1103553-A2 | Substituted heterocyclic derivatives | Pfizer Products Inc. (US) | 2001-05-30 | — | — | EP | claimed |
| US-6525067-B1 | Corticotropin releasing factor antagonists; such as 1-(2-methyl-8-(2,4,6-trimethyl-phenyl)-quinolin-4-yl)-propan-1-one-oxime | PFIZER INC | 2003-02-25 | — | — | US | disclosed |
| EP-1103553-A2 | Substituted heterocyclic derivatives | Pfizer Products Inc. (US) | 2001-05-30 | — | — | EP | disclosed |